METTL3 and hepatocellular carcinoma: Moreover, the imbalance of METTL3 promotes the occurrence of HCC and chemotherapy resistance by regulating the phosphorylation pathway of METTL3/SOCS2/STAT5, which refers to key anti-oncogenes at the post-transcriptional level (21).